
Episode 217: AI therapists, theta-bursts for depression, finerenone for CKD, and GLP-1s causing vision loss.
7.10.2026
0:00
32:00
This week, Henry, Kate, Gary and Mark talk about 4 great new studies: is using an AI chat therapist really that bad for youth, theta-burst stimulation for adults with major depressive disorder, finerenone in adults with CKD but not DM, and GLP-1 agonists and vision loss risk.
Więcej odcinków z kanału "Primary Care Update"



Nie przegap odcinka z kanału “Primary Care Update”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








